Pankit Vachhani, MD, is an associate professor of medicine at the University of Alabama at Birmingham.
Post-Hoc Analysis Evaluates Ruxolitinib Plus Anemia-Supportive Therapies in Myelofibrosis: Pankit Vachhani, MD
A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according to Pankit Vachhani, MD.